People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Algaeon, Inc. | — | Biotechnology | Pre-Seed | $1.9M | $14.5M | 2013 |
Matthew A. Hall at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matthew A. Hall on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| JAMES R. MILLER | 1 | 4 |
| Paul W. DeLacey | 1 | 1 |
| John A. Kassebaum | 1 | 1 |
| William R. Kassebaum | 1 | 1 |
| Mike D. Neibler | 1 | 1 |
| David A. Spoelstra | 1 | 1 |
| Jonathan D. Rosen | 1 | 1 |
| Michael E. Bosway | 1 | 1 |
| Brian D. Stemme | 1 | 1 |
| Kip R. Zurcher | 1 | 1 |
| Viren K. Grover | 1 | 1 |
| Anthony A. Hubbard | 1 | 1 |
| Mike A. Neibler | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.